All In MedTech

Device Trial Radar · NCT07801443

Focused Ultrasound Stimulation for the Treatment of Chronic Pain

Safety, Feasibility, and Biomarker Characterization Study of ATTN201 Repeated Centromedian Thalamic Nucleus Focused Ultrasound Stimulation for the Treatment of Chronic Pain

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Sep 4, 2026

Primary completion

Dec 27, 2027

Study completion Mar 30, 2028

Sponsor

Lead sponsor
Attune Neurosciences IncNot on our public-company list
Sponsor type
Industry
First posted
Sep 3, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

ATTN201 is a non-invasive focused ultrasound neurostimulation device that delivers offline MRI-guided non-invasive focused ultrasound to target brain areas. A cranial MRI is obtained before starting treatment while subjects wear a MR-compatible fiducial laced version of the wearable to co-register the cranial coordinate system with transducer coordinates. Simulations will define ultrasound focusing instructions for each patient to specifically target their brain area. For 100+ participants, we will also continuously monitor multiple interstitial pain biomarkers over the course of the intervention.

Conditions

  • Chronic Pain

Interventions

  • ATTN201 focused ultrasound systemDevice

    Head-worn low intensity focused ultrasound

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Brief Pain Inventory - Short Form (BPI-SF) Pain Severity Subscale ScoreTime frame: Baseline (Day 0) and Day 14

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Attune Neurosciences, Inc.

    San Francisco, California · Recruiting

  • Attune, San Francisco Clinical Research Center

    San Francisco, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.